 |
|
Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke
Georgios Tsivgoulis, Apostolos Safouris, Dong-Eog Kim, Andrei V. Alexandrov
J Stroke. 2018;20(3):417-417. Published online 2018 Jun 29 DOI: https://doi.org/10.5853/jos.2018.00773.e1
|
|
Citations to this article as recorded by
 Current trends and future perspectives for enhanced drug delivery to central nervous system in treatment of stroke
Rajalakshmi Rajendran, Arundhasree Kunnil, Aiswarya Radhakrishnan, Sachin Thomas, Sreeja Chandrasekharan Nair
Therapeutic Delivery.2023; 14(1): 61. CrossRef Interdisciplinary modelâinformed drug development for extending duration of elagolix treatment in patients with uterine fibroids
Denise Beck, Insa Winzenborg, Wei Gao, Nael M. Mostafa, Stephanie E. Chiuve, Charlotte Owens, Mohamad Shebley
British Journal of Clinical Pharmacology.2022; 88(12): 5257. CrossRef Body Mass Index and Prognosis in Ischemic Stroke Patients With Type 2 Diabetes Mellitus
Hyungjong Park, Hyung Woo Lee, Joonsang Yoo, Hye Sun Lee, Hyo Suk Nam, Young Dae Kim, Ji Hoe Heo
Frontiers in Neurology.2019;[Epub] CrossRef
|